Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Analyst Favorites With Strong Buyback Activity: ViroPharma Ranks As a Top Pick
Forbes
Wednesday, April 24, 2013 - 4:50pm
tags:
ViroPharma
Will The Big Pharmaceuticals Fall Off A Patent Cliff?
Seeking Alpha
Wednesday, April 24, 2013 - 4:47pm
tags:
patent cliff, patents, GSK, Eli Lilly, AstraZeneca, Merck, Pfizer
2 Orphan Drugmakers With Upcoming Catalysts
Seeking Alpha
Wednesday, April 24, 2013 - 4:46pm
tags:
orphan drugs, Raptor Pharmaceuticals, Aegerion, Juxtapid, procysbi
Glaxo Profit Falls on Divestments as Approvals Awaited
Bloomberg
Wednesday, April 24, 2013 - 10:30am
tags:
earnings, GSK
FDA Discouraging Real-Time Release Testing as a Shortcut to End Testing, Experts Say
in-Pharma Technologist
Wednesday, April 24, 2013 - 10:29am
tags:
R&D
Quickly Approaching Biopharma Catalyst Events
Seeking Alpha
Wednesday, April 24, 2013 - 10:27am
tags:
Agenus, Aveo Pharmaceuticals, Insmed, GSK, Sarepta
Arena Faces A Convergence Of DEA And European Decisions
Seeking Alpha
Wednesday, April 24, 2013 - 10:25am
tags:
Arena Pharmaceuticals, Europe, DEA, Eisai, Vivus, Orexigen
OPKO Health To Acquire PROLOR Biotech
Yahoo
Wednesday, April 24, 2013 - 10:24am
tags:
OPKO Health, Prolor Biotech, M&A
Vertex Spikes On Phase II Data, Then The CFO Sells His Shares
Seeking Alpha
Wednesday, April 24, 2013 - 10:23am
tags:
Vertex Pharmaceuticals, VX-661, cystic fibrosis
Amgen 1Q profit up 21 pct on lower taxes, expenses
Yahoo/AP
Wednesday, April 24, 2013 - 10:21am
tags:
earnings, Amgen
AcelRx pain drug shows mixed results in mid-stage trial
Reuters
Wednesday, April 24, 2013 - 10:20am
tags:
AcelRx, painkillers
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Seeking Alpha
Wednesday, April 24, 2013 - 10:19am
tags:
Aveo Pharmaceuticals, FDA, tivozanib, GSK, Onyx, Pfizer, renal cell carcinoma, Roche
The Medicines Company Reports First Quarter 2013 Financial Results
Yahoo
Wednesday, April 24, 2013 - 9:41am
tags:
earnings, Medicines Company
An Undervalued Pharmaceutical Company With Remarkable Results
Seeking Alpha
Wednesday, April 24, 2013 - 9:40am
tags:
Teva
For Iluvien, The FDA Isn't The Issue; European Sales Are
Seeking Alpha
Wednesday, April 24, 2013 - 9:37am
tags:
FDA, Iluvien, DME, diabetic macular edema, pSivida, Alimera
Eli Lilly Profit Beats Estimates on Lower Costs
Bloomberg
Wednesday, April 24, 2013 - 9:35am
tags:
earnings, Eli Lilly
Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Yahoo/AP
Wednesday, April 24, 2013 - 9:34am
tags:
Merck, lambrolizumab, FDA, MK-3475, melanoma
Novartis posts profit gain thanks to new drugs
Yahoo/AP
Wednesday, April 24, 2013 - 9:33am
tags:
earnings, Novartis
Boehringer anti-clotting pill gains blockbuster status
Reuters
Wednesday, April 24, 2013 - 8:47am
tags:
anticoagulants, Boehringer Ingelheim, Pradaxa
Elan sees sales of prized Tysabri drug rise sharply
Reuters
Wednesday, April 24, 2013 - 8:46am
tags:
Elan, Royalty Pharma, M&A, Tysabri

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.